SCHEMBL19291815

SCHEMBL19291815

CCC[C@H](O)COc1cccc(C(O)CCN)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.47
MAPK1 P28482 2/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEN1 O00255 1/20 0.44
GMNN O75496 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
ALOX5 P09917 1/20 0.44
HPGD P15428 1/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
MTOR P42345 1/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2205422 1.00 HIF1A (0.47) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL29818688 1.00 HIF1A (0.47) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL11996500 0.92 MAPK1 (0.47) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL4568899 0.92 HIF1A (0.51) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL2205459 0.89 MAPK1 (0.46) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL13881638 0.89 MAPK1 (0.46) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL29818796 0.89 MAPK1 (0.46) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL13881570 0.89 MAPK1 (0.46) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL17031426 0.87 MAPK1 (0.42) HIF1AMAPK1TP53CYP1A2CYP3A4
SCHEMBL15907831 0.87 MAPK1 (0.42) HIF1AMAPK1TP53CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3210966-A1 ALKOXYPHENYLPROPYLAMINES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION Acucela, Inc. (US) 2017-08-30 EP disclosed